# Areteia Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/areteia-therapeutics

- Industry: Biotechnology
- Headquarters: Chapel Hill, US
- Website: www.areteiatx.com
- Total disclosed funding: $275M
- Latest round: Series A (Feb 13, 2024)
- Investors on record: 10

## About

Based in North Carolina, US, Areteia Therapeutics, Inc. was created by Population Health Partners and Knopp Biosciences in 2022 and is a biopharmaceutical company in its clinical stage that develops an oral drug for eosinophilic asthma.

In February 2024, Areteia Therapeutics, Inc. raised USD 75 million in series A funding led by returning investor Bain Capital Life Sciences, with participation from new investors Viking Global Investors and Marshall Wace. Returning investors Access Industries, GV, ARCH Venture Partners, Saturn Partners, Sanofi, Maverick Capital, and Population Health Partners also participated in the round. 

The round was part of a larger USD 425 million series A funding. 



The company is conducting clinical trials of its oral medicine dexpramipexole, which has the potential to target eosinophils in the blood and prevent them from traveling through the blood to the lungs of people suffering from eosinophilic asthma and reducing their effect on the lungs before they cause further damage.

The company intends to use the July 2022 funding to promote its advanced dexpramipexole through Phase 3 clinical trials, secure commercial supply, and pursue potential next-generation medicines.

## Funding rounds

- Series A, Feb 13, 2024, $100M — Marshall Wace, Viking Global Investors
- Series A, Jun 15, 2022, $175M — ARCH Venture Partners, Access Industries, GV, Maverick Capital, Saturn Partners, Sanofi, Bain Capital Life Sciences, Population Health Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- Access Industries (https://capitalatlas.ai/funds/access-industries) — Series A
- GV (https://capitalatlas.ai/funds/gv) — Series A
- Maverick Capital (https://capitalatlas.ai/funds/maverick-capital) — Series A
- Saturn Partners (https://capitalatlas.ai/funds/saturn-partners) — Series A
- Sanofi — Series A
- Bain Capital Life Sciences — Series A
- Population Health Partners (https://capitalatlas.ai/funds/population-health-partners) — Series A
- Marshall Wace (https://capitalatlas.ai/funds/marshall-wace) — Series A
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series A